Welcome to #NeuroRigBuilder!

Javascript is disabled!

Our site was designed and built for using JavaScript technology.
For full functionality of this site it is necessary to enable JavaScript.
Here are the instructions how to do it in your web browser.

The #NeuroRigBuilder Team

Osmotic pump - 200ul - 3 days
https://www.neurorigbuilder.com #NeuroRigBuilder

Find this product here:
In vivo applications / Osmotic Pump

Osmotic Pump

Osmotic pump - 200ul - 3 days

RWD osmotic pump is a precise drug delivery tool. Usually 3 days, 1 week, and 2 weeks dosing a slow-release pump requires 6-8, 12-24, 24-48 hours of incubation, after which the slow-release pump can administer the drug at a constant rate.
The package contains 10 pieces.



Lead time:
Max. 5 weeks

RWD osmotic pump is a precise drug delivery tool. Usually, 3 days, 1 week, and 2 weeks dosing a slow-release pump requires 6-8, 12-24, 24-48 hours of incubation, after which the slow-release pump can administer the drug at a constant rate (within a predictable range). The liquid pump is released until only about 5% of the solution remains in the storage tank, and then the rate drops to zero. The method RWD uses to estimate the pumping rate of the osmotic pump is to measure the pumping rate of the slow-release pump in 37% (± 0.5°C) 0.9% saline in vitro. This in vitro test method has good reproducibility, whether it is the test of the same batch of slow-release pumps or different batches of slow-release pumps at different periods, and is used to estimate the pump's expected pumping rate. For example, in rats and mice, the deviation of the subcutaneous or intraperitoneal pumping rate of the implanted micro sustained-release pump from the in vitro rate is within 5%.

  • Simple, convenient, reliable, low cost.
  • No battery, no power supply, no mobile module.
  • High repeatability and continuity.
  • Minimal side effects on animals and stress interference. 

The catheter can be introduced into different sites, such as the cranial cavity and spinal cord, intravascular, liver, spleen, and other organs and trauma.

Features:

  • Ensure continuous and uninterrupted administration, maintaining the preset speed for the administration of the animal.
  • Storage capsules have good drug compatibility and protection for short half-life drugs.
  • Capsules have good biocompatibility and do not affect the physiology of animals.
  • Easy to use, an experiment requires only one administration, no longer need night or weekend experiment.
  • Avoid the stress caused by repeated administration, reducing the impact of non-experimental factors on the experimental results.
  • Small size, can be applied to experiments on mice, neonatal rats, and other small animals.
  • Ensure that the drug is delivered to the target site accurately.

táblázat.JPG

 



There are no questions related this product!

Do you have questions? Log in to post questions here!

Descriptions

RWD osmotic pump is a precise drug delivery tool. Usually, 3 days, 1 week, and 2 weeks dosing a slow-release pump requires 6-8, 12-24, 24-48 hours of incubation, after which the slow-release pump can administer the drug at a constant rate (within a predictable range). The liquid pump is released until only about 5% of the solution remains in the storage tank, and then the rate drops to zero. The method RWD uses to estimate the pumping rate of the osmotic pump is to measure the pumping rate of the slow-release pump in 37% (± 0.5°C) 0.9% saline in vitro. This in vitro test method has good reproducibility, whether it is the test of the same batch of slow-release pumps or different batches of slow-release pumps at different periods, and is used to estimate the pump's expected pumping rate. For example, in rats and mice, the deviation of the subcutaneous or intraperitoneal pumping rate of the implanted micro sustained-release pump from the in vitro rate is within 5%.

  • Simple, convenient, reliable, low cost.
  • No battery, no power supply, no mobile module.
  • High repeatability and continuity.
  • Minimal side effects on animals and stress interference. 

The catheter can be introduced into different sites, such as the cranial cavity and spinal cord, intravascular, liver, spleen, and other organs and trauma.

Features:

  • Ensure continuous and uninterrupted administration, maintaining the preset speed for the administration of the animal.
  • Storage capsules have good drug compatibility and protection for short half-life drugs.
  • Capsules have good biocompatibility and do not affect the physiology of animals.
  • Easy to use, an experiment requires only one administration, no longer need night or weekend experiment.
  • Avoid the stress caused by repeated administration, reducing the impact of non-experimental factors on the experimental results.
  • Small size, can be applied to experiments on mice, neonatal rats, and other small animals.
  • Ensure that the drug is delivered to the target site accurately.

táblázat.JPG

 





Q&As
There are no questions related this product!

Do you have questions? Log in to post questions here!


Comments
There are no comments related to this product!

Do you have comments? Please to post comments here!


All images shown are for illustration purpose only. See details in Terms.
https://www.neurorigbuilder.com #NeuroRigBuilder